Stay connected to our news and events via the Celanese social channel experience and see where we are improving the world through our people, products and processes.

Celanese Healthcare
Search Menu

Menu

Close
Contact Us

Healthcare and Life
Sciences Solutions

Celanese Healthcare Products and Solutions Vitaldose® EVA
LADD_products_Vitaldose_page-header

VitalDose® EVA

Vitaldose® EVA
Regulatory Experience Chemistry of Vitaldose® EVA Process Versatility Literature/Papers
Contact Us

Recommended Literature

Vitaldose® Technology Platform for Innovative Drug-Eluting Implants

Safe and Effective Sustained Release Excipients for Better Ocular Drug Delivery

EVA Foamed Excipient: Novel Way To Deliver Stem Cells, Growth Factors And Biologics For Controlled Release Applications

Celanese’s VitalDose® EVA copolymer is an enabling technology for drug-eluting implants. VitalDose® EVA is a technology platform for reliable controlled-release performance in long-acting indications. Common applications include subcutaneous and surgical implants, intravitreal and extraocular devices and intravaginal rings. Therapeutics in these forms address unmet clinical needs across multiple segments including those in oncology, ophthalmology, infectious disease and Women’s Health.

When you engage with our pharmaceutical development and feasibility lab, you can access resources to accelerate development time and speed to market for your controlled release pharmaceutical application. Available development lab services include:

  • Formulation development
  • Drug release testing
  • Form factor development
  • Prototyping
  • And more

Learn about these services and the VitalDose® EVA SELECT option for those with internal development resources.

Celanese’s VitalDose® EVA Copolymer Platform

  • VitalDose® EVA is biostable making it possible to engineer dosing profiles (Zero-order, First-order or other nonlinear profiles) over lengthy rations.
  • The polymer’s durability ensures implants can be reliably removed to halt therapy when required.
  • High drug loadings (>75%) are possible while maintaining desired tactile properties.
  • The technology platform is compatible with proteins, peptides and small molecules.
  • Pharmaceutical formulators and device developers can rely on the clinical history of VitalDose® EVA.
Uses of Vitaldose EVA

VitalDose® EVA Product Form Factors

VitalDose EVA Product Form Factors

Let us help

Contact us for help with customization

This website uses 'cookies' to give you the best, most relevant experience. Using this website means you are Ok with this. You can change which cookies are set at any time - and find out more about them - by following this link.

Information on the processing of your personal data within the USA by Google and Marketo:
By clicking "Accept All", or selecting "Marketing" and/or "Analytical" and then clicking "Accept Selected", you also consent in accordance with Art. 49(1)(a) GDPR that your data may be processed in the USA. The USA is considered by the European Court of Justice to be a country with no adequate level of data protection according to EU standards. In particular, there is a risk that your data may be processed by US authorities for surveillance and investigation purposes, possibly without the opportunity for legal remedies. If you select “Necessary” and then click on "Accept Selected”, the transfer described above will not take place. You will find more detailed information in our privacy policy.